Comparison between GPT Healthcare IPO and Krystal Integrated IPO.
GPT Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Krystal Integrated IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of GPT Healthcare IPO is up to ₹525.14 Cr whereas the issue size of the Krystal Integrated IPO is up to ₹300.12 Cr. The final issue price of GPT Healthcare IPO is ₹186.00 per share and of Krystal Integrated IPO is ₹715.00 per share.
| GPT Healthcare IPO | Krystal Integrated IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹177.00 per share | ₹680.00 per share |
| Issue Price (Upper) | ₹186.00 per share | ₹715.00 per share |
| Issue Price (Final) | ₹186.00 per share | ₹715.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 80 shares | 20 shares |
| Fresh Issue Size | 21,50,537 shares | 24,47,552 shares |
| Fresh Issue Size (Amount) | up to ₹40.00 Cr | up to ₹175.00 Cr |
| OFS Issue Size | 2,60,82,786 shares | 17,50,000 shares |
| OFS Issue Size (Amount) | up to ₹485.14 Cr | up to ₹125.13 Cr |
| Issue Size Total | 2,82,33,323 shares | 41,97,552 shares |
| Issue Size Total (Amount) | up to ₹525.14 Cr | up to ₹300.12 Cr |
GPT Healthcare IPO opens on Feb 22, 2024, while Krystal Integrated IPO opens on Mar 14, 2024. The closing date of GPT Healthcare IPO and Krystal Integrated IPO is Feb 26, 2024, and Mar 18, 2024, respectively.
| GPT Healthcare IPO | Krystal Integrated IPO | |
|---|---|---|
| Anchor Bid Date | Feb 21, 2024 | Mar 13, 2024 |
| Issue Open | Feb 22, 2024 | Mar 14, 2024 |
| Issue Close | Feb 26, 2024 | Mar 18, 2024 |
| Basis Of Allotment (Tentative) | Feb 27, 2024 | Mar 19, 2024 |
| Initiation of Refunds (Tentative) | Feb 28, 2024 | Mar 20, 2024 |
| Credit of Share (Tentative) | Feb 28, 2024 | Mar 20, 2024 |
| Listing date (Tentative) | Feb 29, 2024 | Mar 21, 2024 |
| Anchor Lockin End date 1 | Mar 28, 2024 | Apr 18, 2024 |
| Anchor Lockin End date 2 | May 27, 2024 | Jun 17, 2024 |
GPT Healthcare IPO P/E ratio is 38.1, as compared to Krystal Integrated IPO P/E ratio of 21.45.
| GPT Healthcare IPO | Krystal Integrated IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 67.34 | 99.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 38.1 | 21.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹1526.22 Cr. | ₹998.99 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.59% | 11.71% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.09% | 16.97% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.39 | 0.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.88 | ₹33.33 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 23.77% | 11.21% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the GPT Healthcare IPO Retail Individual Investors (RII) are offered 98,81,664 shares while in Krystal Integrated IPO retail investors are offered 98,81,664 shares. Qualified Institutional Buyers (QIB) are offered 56,46,664 shares in GPT Healthcare IPO and 8,39,510 shares in Krystal Integrated IPO.
| GPT Healthcare IPO | Krystal Integrated IPO | |
|---|---|---|
| Anchor Investor Reservation | 84,69,996 shares | 12,59,265 shares |
| Market Maker Reservation | ||
| QIB | 56,46,664 shares | 8,39,510 shares |
| NII | 42,34,999 shares | 6,29,633 shares |
| RII | 98,81,664 shares | 14,69,144 shares |
| Employee | ||
| Others | ||
| Total | 2,82,33,323 shares | 41,97,552 shares |
GPT Healthcare IPO subscribed 8.52x in total, whereas Krystal Integrated IPO subscribed 13.49x.
| GPT Healthcare IPO | Krystal Integrated IPO | |
|---|---|---|
| QIB (times) | 17.30x | 7.32x |
| NII (times) | 11.02x | 45.23x |
| Big NII (times) | 11.98x | 52.07x |
| Small NII (times) | 9.09x | 31.54x |
| RII (times) | 2.44x | 3.42x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.52x | 13.49x |
